New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 28, 2013
08:30 EDTALXNAlexion weakness would be buying opportunity, says Deutsche Bank
Deutsche Bank believes any weakness in shares of Alexion from the company's FDA warning letter would be a buying opportunity. Deutsche thinks the letter will not be impactful to Soliris and points out the company has sufficient inventory on hand.
News For ALXN From The Last 14 Days
Check below for free stories on ALXN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
07:52 EDTALXNAlexion says Soliris production not interrupted by FDA facility inspection
Subscribe for More Information
06:31 EDTALXNAlexion initiates multinational registration trial of eculizumab
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use